TY - JOUR
T1 - Possible involvement of rho-kinase in aldosterone-induced vascular smooth muscle cell remodeling
AU - Miyata, Kayoko
AU - Hitomi, Hirofumi
AU - Guo, Peng
AU - Zhang, Guo Xing
AU - Kimura, Shoji
AU - Kiyomoto, Hideyasu
AU - Hosomi, Naohisa
AU - Kagami, Shoji
AU - Kohno, Masakazu
AU - Nishiyama, Akira
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2008
Y1 - 2008
N2 - There is increasing evidence supporting potential roles of aldosterone in the pathogenesis of vascular injury. The present study aimed to determine the involvement of Rho-kinase in aldosterone-induced vascular smooth muscle cell (VSMC) remodeling. In cultured rat VSMC, the effects of aldosterone on Rho-kinase activity, the reorganization of the cytoskeleton and cellular migration were examined. Aldosterone (1 nmol/ L) significantly increased phosphorylation of myosin phosphate target subunit-1 (MYPT1), a marker of Rhokinase activity, and the amount of GTP-Rho with a peak at 90 min in VSMC. Aldosterone also stimulated VSMC stress fiber formation and migration. These effects of aldosterone were markedly attenuated by pretreatment with eplerenone (10 μmol/L), a selective mineralocorticoid receptor antagonist, or Y27632 (10 μmol/ L), a specific Rho-kinase inhibitor. These findings indicate that Rho-kinase is involved in the pathogenesis of aldosterone-induced VSMC remodeling.
AB - There is increasing evidence supporting potential roles of aldosterone in the pathogenesis of vascular injury. The present study aimed to determine the involvement of Rho-kinase in aldosterone-induced vascular smooth muscle cell (VSMC) remodeling. In cultured rat VSMC, the effects of aldosterone on Rho-kinase activity, the reorganization of the cytoskeleton and cellular migration were examined. Aldosterone (1 nmol/ L) significantly increased phosphorylation of myosin phosphate target subunit-1 (MYPT1), a marker of Rhokinase activity, and the amount of GTP-Rho with a peak at 90 min in VSMC. Aldosterone also stimulated VSMC stress fiber formation and migration. These effects of aldosterone were markedly attenuated by pretreatment with eplerenone (10 μmol/L), a selective mineralocorticoid receptor antagonist, or Y27632 (10 μmol/ L), a specific Rho-kinase inhibitor. These findings indicate that Rho-kinase is involved in the pathogenesis of aldosterone-induced VSMC remodeling.
KW - Aldosterone
KW - Eplerenone
KW - Mineralocorticoid receptor
KW - Rho-kinase
KW - Vascular smooth muscle cells
UR - http://www.scopus.com/inward/record.url?scp=55449120174&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=55449120174&partnerID=8YFLogxK
U2 - 10.1291/hypres.31.1407
DO - 10.1291/hypres.31.1407
M3 - Article
C2 - 18957812
AN - SCOPUS:55449120174
SN - 0916-9636
VL - 31
SP - 1407
EP - 1413
JO - Hypertension Research
JF - Hypertension Research
IS - 7
ER -